StonvexLoading…
StonvexStonvexStonvexCore line items from ALNY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.71B | $2.25B | $1.83B | $1.04B |
Operating Income | $501.58M | $-176.88M | $-282.18M | $-785.07M |
Net Income | $313.75M | $-278.16M | $-440.24M | $-1.13B |
EPS (Diluted) | $2.33 | $-2.18 | $-3.52 | $-9.30 |
Total Assets | $4.97B | $4.24B | $3.83B | $3.55B |
Total Liabilities | $4.18B | $4.17B | $4.05B | $3.70B |
Cash & Equivalents | $1.66B | $966.43M | $812.69M | $866.39M |
Free Cash Flow OCF − CapEx | $465.38M | $-42.59M | $41.95M | $-613.33M |
Shares Outstanding | 132.38M | 129.29M | 125.79M | 123.92M |